Overview A phase 2 study conducted, by Dr. Richard A. Nash, on 24 patients with relapsing-remitting MS showed extremely positive results, with 86% of patients relapse free for three years….
In Duchenne Muscular Dystrophy Stem Cells Found to be Faulty
Overview In a new study by Stanford University Medical Center mice with a form of Duchenne Muscular Dystrophy (DMD)underwent progressive muscle degeneration and accumulated connective tissue as they aged. Now,…
Source Concord Acquires Beike Biotechnology Shares
On the evening of December 22, the Source Concord Cell Gene Engineering Co., Ltd. (Source Concord) announced a 13 percent (118.7 million yuan) acquisition of shares held by Dr. Xiang…
Altor BioScience and Shenzhen Beike Biotechnology Announce License Agreement for Immunotherapeutic ALT-803 in China
MIRAMAR, Fla. & SHENZHEN, China, Sep 10, 2014 (BUSINESS WIRE) — Altor BioScience Corporation (Altor), a U.S.-based developer of novel cancer immunotherapies, and Shenzhen Beike Biotechnology Co., Ltd. (Beike), a…
Ice Bucket Challenge Sweeps China
On a hot and sunny day in coastal Shenzhen, China, a small group of Beike Biotechnology’s international department was preparing to dump buckets of ice water on themselves. Why? More…
Taizhou City, Jiangsu Province, China August 8, 2014 / PRNewswire / – In recent years, with the rapid development of stem cell biology, immunology, molecular techniques, tissue engineering and other…